UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000044771
Receipt No. R000051061
Scientific Title Change in aqueous cytokine level after intravitreal anti-VEGF therapy in diabetic macular edema
Date of disclosure of the study information 2021/07/06
Last modified on 2021/07/06 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Change in aqueous cytokine level after intravitreal anti-VEGF therapy in diabetic macular edema
Acronym the effect of anti-VEGF therapy on aqueous cytokine level in DME
Scientific Title Change in aqueous cytokine level after intravitreal anti-VEGF therapy in diabetic macular edema
Scientific Title:Acronym the effect of anti-VEGF therapy on aqueous cytokine level in DME
Region
Japan

Condition
Condition diabetic macular edema
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to evaluate the effect of anti-VEGF therapy on aqueous cytokine level.
Basic objectives2 Others
Basic objectives -Others the relationship between the change of cytokine level and therapeutic effect
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the change in aqueous cytokine level
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Maneuver
Interventions/Control_1 aqueous humor collection
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria DME patients who receive anti VEGF agent.
Key exclusion criteria treatment history (surgery or photocoagulation) in 3 months.
allergy
pregnant
participating any other study

Target sample size 40

Research contact person
Name of lead principal investigator
1st name masakazu
Middle name
Last name morioka
Organization Fukui University
Division name ophthalmology
Zip code 9101193
Address shimoaizuki, matsuoka, eiheijicho, Fukui
TEL 0776613111
Email mmorioka@u-fukui.ac.jp

Public contact
Name of contact person
1st name masakazu
Middle name
Last name morioka
Organization Fukui University
Division name Ophthalmology
Zip code 9101193
Address shimoaizuki, matsuoka, eiheijicho, Fukui
TEL 0776613111
Homepage URL
Email mmorioka@u-fukui.ac.jp

Sponsor
Institute Fukui University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Fukui University IRB
Address shimoaizuki, matsuoka, eiheijicho, Fukui
Tel 0776613111
Email mmorioka@u-fukui.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 01 Month 27 Day
Date of IRB
2021 Year 01 Month 27 Day
Anticipated trial start date
2021 Year 01 Month 27 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 07 Month 06 Day
Last modified on
2021 Year 07 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051061